Wolverine Trading’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,974
| Closed | -$212K | – | 1883 |
|
|
2025
Q1 | $212K | Buy |
+1,974
| New | +$212K | ﹤0.01% | 1034 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2037 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1848 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1630 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1786 |
|
|
2022
Q1 | – | Sell |
-2,092
| Closed | -$204K | – | 2136 |
|
|
2021
Q4 | $204K | Buy |
+2,092
| New | +$204K | ﹤0.01% | 1314 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2351 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2272 |
|
|
2020
Q1 | – | Sell |
-8,312
| Closed | -$539K | – | 1718 |
|
|
2019
Q4 | $539K | Sell |
8,312
-12,280
| -60% | -$796K | ﹤0.01% | 850 |
|
|
2019
Q3 | $1.27M | Sell |
20,592
-4,844
| -19% | -$299K | ﹤0.01% | 339 |
|
|
2019
Q2 | $1.81M | Sell |
25,436
-28,899
| -53% | -$2.06M | 0.01% | 259 |
|
|
2019
Q1 | $4.26M | Buy |
54,335
+29,936
| +123% | +$2.35M | 0.01% | 110 |
|
|
2018
Q4 | $2.07M | Buy |
+24,399
| New | +$2.07M | 0.01% | 243 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 1838 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1873 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1649 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1635 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1663 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1654 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 1595 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 1209 |
|